Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients

Παρόμοια τεκμήρια

• Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial
  από: Jianming Xu, κ.ά.
  Έκδοση: (2021-01-01)
• HX008: a humanized PD-1 blocking antibody with potent antitumor activity and superior pharmacologic properties
  από: Jibin Zhang, κ.ά.
  Έκδοση: (2020-01-01)
• Phase I study of pucotenlimab (HX008), an anti-PD-1 antibody, for patients with advanced solid tumors
  από: Rujiao Liu, κ.ά.
  Έκδοση: (2021-05-01)
• Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study
  από: Chuanliang Cui, κ.ά.
  Έκδοση: (2023-02-01)
• From HX-Groups to HX-Polygroups
  από: Seyed Sh. Mousavi, κ.ά.
  Έκδοση: (2023-12-01)